MSD Innovation Factory: INNOREP Challenge - Creating Memorable Experiences for Healthcare Professionals

MSD Innovation FactoryNowadays, pharmaceutical launches are becoming harder and more competitive. In some cases, MSD products are neither the only nor the first player in the market. Besides, clinical data can be comparable with the products of other laboratories.

Healthcare professionals tend to prescribe the products that they are familiar with and knowledgeable about (what is known as 'top of mind'). Therefore, all pharmaceutical companies focus on face-to-face interaction done by representatives (reps) as an anchor for the exchange of product scientific information with the healthcare professionals.

It is hard for the healthcare professionals to remember the features and value of MSD products due to the limited time they spend with MSD reps, the overall number of reps the see per week (more than 10) together with the cognitive overload and fatigue of dealing with approximately 4 products per interaction.

On average, 87% of healthcare professionals contacts with pharmaceutical sales reps last less than two minutes, which is not enough for impactful product discussion.

Currently MSD sales reps are equipped with Tablets and Laptops for their daily job. However, based on experience, using them in the wrong way can distract the physician from the conversation.

The need
Help MSD reps to set themselves apart from the other reps while interacting with healthcare professionals. MSD is looking for innovative solutions or approaches to support the interaction with healthcare professionals in an ethical unique, engaging and memorable manner.

Expected outputs
Innovative, engaging and impactful solution or approach for having scientific discussions with healthcare professionals and key stakeholders, taking full advantage of the MSD product studies, clinical papers and scientific materials. The solution or approach should be cost-effective. Please refer to the rules for further information on permissible solutions

Deadline date: December 30th 2016, 23:59:59 UTC

For further information and to apply, please visit:
http://www.msdinnovationfactory.com

About MSD (EEMEA)
MSD (in the United States and Canada known as Merck & Co., Inc., Kenilworth, NJ USA) during its 125 years of successful health and medicines innovation achievements is eager to find new and better ways to provide breakthrough medicines and healthcare services to patients and healthcare professionals around the world converging to a new stage of co creation now with the Health Tech Eco System.

That is why the EEMEA (Eastern Europe, Middle East and Africa) MSD Organization is opening the doors for entrepreneurs and ideators to come up with articulable solutions for 3 of our most important needs across all countries within this geographical region. A total of 9 finalists (3 for each need/challenge) will not only have the opportunity to showcase their proposal and debate with MSD experts how to co create together but also will have the chance to earn 3.000€ if selected as the most articulate and innovative solution.

The EEMEA Innovation Factory has been launched in partnership with TICBioMed a Digital Health association specialized in providing business support.

Most Popular Now

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...

New Research Shows Promise and Limitatio…

Published in JAMA Network Open, a collaborative team of researchers from the University of Minnesota Medical School, Stanford University, Beth Israel Deaconess Medical Center and the University of Virginia studied...

G-Cloud 14 Makes it Easier for NHS to Bu…

NHS organisations will be able to save valuable time and resource in the procurement of technologies that can make a significant difference to patient experience, in the latest iteration of...

Hampshire Emergency Departments Digitise…

Emergency departments in three hospitals across Hampshire Hospitals NHS Foundation Trust have deployed Alcidion's Miya Emergency, digitising paper processes, saving clinical teams time, automating tasks, and providing trust-wide visibility of...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

MEDICA HEALTH IT FORUM: Success in Maste…

11 - 14 November 2024, Düsseldorf, Germany. How can innovations help to master the great challenges and demands with which healthcare is confronted across international borders? This central question will be...

A "Chemical ChatGPT" for New M…

Researchers from the University of Bonn have trained an AI process to predict potential active ingredients with special properties. Therefore, they derived a chemical language model - a kind of...

Siemens Healthineers co-leads EU Project…

Siemens Healthineers is joining forces with more than 20 industry and public partners, including seven leading stroke hospitals, to improve stroke management for patients all over Europe. With a total...

MEDICA and COMPAMED 2024: Shining a Ligh…

11 - 14 November 2024, Düsseldorf, Germany. Christian Grosser, Director Health & Medical Technologies, is looking forward to events getting under way: "From next Monday to Thursday, we will once again...

In 10 Seconds, an AI Model Detects Cance…

Researchers have developed an AI powered model that - in 10 seconds - can determine during surgery if any part of a cancerous brain tumor that could be removed remains...

Does AI Improve Doctors' Diagnoses?

With hospitals already deploying artificial intelligence to improve patient care, a new study has found that using Chat GPT Plus does not significantly improve the accuracy of doctors' diagnoses when...

AI Analysis of PET/CT Images can Predict…

Dr. Watanabe and his teams from Niigata University have revealed that PET/CT image analysis using artificial intelligence (AI) can predict the occurrence of interstitial lung disease, known as a serious...